Archives of Clinical Infectious Diseases

Published by: Kowsar

In Vivo Therapeutic Effects of Four Synthesized Antileishmanial Nanodrugs in the Treatment of Leishmaniasis

Tahereh Zadeh Mehrizi 1 , Nariman Mosaffa 2 , Mostafa Haji Molla Hoseini‎ 2 , Mehdi Shafiee Ardestani 3 , ** , Ali Khamesipour 4 , Hasan Ebrahimi Shahmabadi 5 , Mostafa Pirali Hamedani 6 , Yasaman Mardani Dashti 7 and Amitis Ramezani 1 , *
Authors Information
1 Department of Clinical Research, Pasteur Institute of Iran, Tehran, Iran
2 Department of Medical Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3 Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
4 Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
5 Department of Microbiology, Faculty of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
6 Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
7 Islamic Azad University, Medical Branch, Tehran, Iran
Corresponding Authors:
Article information
  • Archives of Clinical Infectious Diseases: October 2018, 13 (5); e80314
  • Published Online: October 3, 2018
  • Article Type: Research Article
  • Received: June 9, 2018
  • Revised: September 1, 2018
  • Accepted: September 9, 2018
  • DOI: 10.5812/archcid.80314

To Cite: Zadeh Mehrizi T, Mosaffa N , Haji Molla Hoseini‎ M, Shafiee Ardestani M, Khamesipour A , et al. In Vivo Therapeutic Effects of Four Synthesized Antileishmanial Nanodrugs in the Treatment of Leishmaniasis, Arch Clin Infect Dis. 2018 ; 13(5):e80314. doi: 10.5812/archcid.80314.

Abstract
Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
References
  • 1. Shirzadi MR, Mollalo A, Yaghoobi-Ershadi MR. Dynamic relations between incidence of zoonotic cutaneous leishmaniasis and climatic factors in Golestan province, Iran. J Arthropod Borne Dis. 2015;9(2):148-60. [PubMed: 26623427]. [PubMed Central: PMC4662787].
  • 2. Saghafipour A, Vatandoost H, Zahraei-Ramazani AR, Yaghoobi-Ershadi MR, Jooshin MK, Rassi Y, et al. Epidemiological study on cutaneous leishmaniasis in an endemic area, of Qom province, central Iran. J Arthropod Borne Dis. 2017;11(3):403-13. [PubMed: 29322057]. [PubMed Central: PMC5758636].
  • 3. Zulfiqar B, Shelper TB, Avery VM. Leishmaniasis drug discovery: Recent progress and challenges in assay development. Drug Discov Today. 2017;22(10):1516-31. doi: 10.1016/j.drudis.2017.06.004. [PubMed: 28647378].
  • 4. Meira CS, Barbosa-Filho JM, Lanfredi-Rangel A, Guimaraes ET, Moreira DR, Soares MB. Antiparasitic evaluation of betulinic acid derivatives reveals effective and selective anti-Trypanosoma cruzi inhibitors. Exp Parasitol. 2016;166:108-15. doi: 10.1016/j.exppara.2016.04.007. [PubMed: 27080160].
  • 5. Bruni N, Stella B, Giraudo L, Della Pepa C, Gastaldi D, Dosio F. Nanostructured delivery systems with improved leishmanicidal activity: A critical review. Int J Nanomedicine. 2017;12:5289-311. doi: 10.2147/IJN.S140363. [PubMed: 28794624]. [PubMed Central: PMC5536235].
  • 6. Jain K, Verma AK, Mishra PR, Jain NK. Surface-engineered dendrimeric nanoconjugates for macrophage-targeted delivery of amphotericin B: Formulation development and in vitro and in vivo evaluation. Antimicrob Agents Chemother. 2015;59(5):2479-87. doi: 10.1128/AAC.04213-14. [PubMed: 25645852]. [PubMed Central: PMC4394771].
  • 7. Jain V, Gupta A, Pawar VK, Asthana S, Jaiswal AK, Dube A, et al. Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles. Appl Biochem Biotechnol. 2014;174(4):1309-30. doi: 10.1007/s12010-014-1084-y. [PubMed: 25106894].
  • 8. Singh PK, Pawar VK, Jaiswal AK, Singh Y, Srikanth CH, Chaurasia M, et al. Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis. Int J Biol Macromol. 2017;105(Pt 1):1220-31. doi: 10.1016/j.ijbiomac.2017.07.161. [PubMed: 28780414].
  • 9. Ribeiro TG, Franca JR, Fuscaldi LL, Santos ML, Duarte MC, Lage PS, et al. An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis. Int J Nanomedicine. 2014;9:5341-53. doi: 10.2147/IJN.S68966. [PubMed: 25429219]. [PubMed Central: PMC4242406].
  • 10. Tripathi P, Jaiswal AK, Dube A, Mishra PR. Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani. Int J Biol Macromol. 2017;105(Pt 1):625-37. doi: 10.1016/j.ijbiomac.2017.07.076. [PubMed: 28716750].
  • 11. Jain K, Verma AK, Mishra PR, Jain NK. Characterization and evaluation of amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers. Nanomedicine. 2015;11(3):705-13. doi: 10.1016/j.nano.2014.11.008. [PubMed: 25596078].
  • 12. Tripathi P, Dwivedi P, Khatik R, Jaiswal AK, Dube A, Shukla P, et al. Development of 4-sulfated N-acetyl galactosamine anchored chitosan nanoparticles: A dual strategy for effective management of Leishmaniasis. Colloids Surf B Biointerfaces. 2015;136:150-9. doi: 10.1016/j.colsurfb.2015.08.037. [PubMed: 26381698].
  • 13. Shahnaz G, Edagwa BJ, McMillan J, Akhtar S, Raza A, Qureshi NA, et al. Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis. Nanomedicine (Lond). 2017;12(2):99-115. doi: 10.2217/nnm-2016-0325. [PubMed: 27879160]. [PubMed Central: PMC5144491].
  • 14. Mehrizi TZ, Ardestani MS, Khamesipour A, Hoseini MHM, Mosaffa N, Anissian A, et al. Reduction toxicity of Amphotericin B through loading into a novel nanoformulation of anionic linear globular dendrimer for improve treatment of leishmania major. J Mater Sci Mater Med. 2018;29(8):125. doi: 10.1007/s10856-018-6122-9. [PubMed: 30056571].
  • 15. Asthana S, Jaiswal AK, Gupta PK, Pawar VK, Dube A, Chourasia MK. Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules. Antimicrob Agents Chemother. 2013;57(4):1714-22. doi: 10.1128/AAC.01984-12. [PubMed: 23357762]. [PubMed Central: PMC3623311].
  • 16. Gupta PK, Jaiswal AK, Asthana S, Verma A, Kumar V, Shukla P, et al. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: Applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis. Pharm Res. 2015;32(5):1727-40. doi: 10.1007/s11095-014-1571-4. [PubMed: 25425053].
  • 17. Daftarian PM, Stone GW, Kovalski L, Kumar M, Vosoughi A, Urbieta M, et al. A targeted and adjuvanted nanocarrier lowers the effective dose of liposomal amphotericin B and enhances adaptive immunity in murine cutaneous leishmaniasis. J Infect Dis. 2013;208(11):1914-22. doi: 10.1093/infdis/jit378. [PubMed: 23901083]. [PubMed Central: PMC3814840].
  • 18. Yue H, Wei W, Yue Z, Lv P, Wang L, Ma G, et al. Particle size affects the cellular response in macrophages. Eur J Pharm Sci. 2010;41(5):650-7. doi: 10.1016/j.ejps.2010.09.006. [PubMed: 20870022].
  • 19. Aguilar Torrentera F, Lambot MA, Laman JD, Van Meurs M, Kiss R, Noel JC, et al. Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana. Am J Trop Med Hyg. 2002;66(3):273-9. [PubMed: 12139220].
  • 20. Chowdhury AR, Mandal S, Goswami A, Ghosh M, Mandal L, Chakraborty D, et al. Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: Implications in antileishmanial therapy. Mol Med. 2003;9(1-2):26-36. [PubMed: 12765337]. [PubMed Central: PMC1430381].
  • 21. Dash SK, Dash SS, Chattopadhyay S, Ghosh T, Tripathy S, Mahapatra SK, et al. Folate decorated delivery of self assembled betulinic acid nano fibers: A biocompatible anti-leukemic therapy. RSC Advances. 2015;5(31):24144-57. doi: 10.1039/c5ra01076d.
  • 22. Liu Y, Gao D, Zhang X, Liu Z, Dai K, Ji B, et al. Antitumor drug effect of betulinic acid mediated by polyethylene glycol modified liposomes. Mater Sci Eng C Mater Biol Appl. 2016;64:124-32. doi: 10.1016/j.msec.2016.03.080. [PubMed: 27127036].
  • 23. Saneja A, Kumar R, Singh A, Dhar Dubey R, Mintoo MJ, Singh G, et al. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy. Int J Pharm. 2017;531(1):153-66. doi: 10.1016/j.ijpharm.2017.08.076. [PubMed: 28823888].
  • 24. Ribeiro TG, Chavez-Fumagalli MA, Valadares DG, Franca JR, Rodrigues LB, Duarte MC, et al. Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system. Int J Nanomedicine. 2014;9:877-90. doi: 10.2147/IJN.S55678. [PubMed: 24627630]. [PubMed Central: PMC3931713].
  • 25. Ribeiro TG, Chavez-Fumagalli MA, Valadares DG, Franca JR, Rodrigues LB, Duarte MC, et al. Novel targeting using nanoparticles: An approach to the development of an effective anti-leishmanial drug-delivery system. Int J Nanomedicine. 2014;9:877-90. doi: 10.2147/IJN.S55678. [PubMed: 24627630]. [PubMed Central: PMC3931713].
  • 26. Dash M, Chiellini F, Ottenbrite RM, Chiellini E. Chitosan-A versatile semi-synthetic polymer in biomedical applications. Prog Polym Sci. 2011;36(8):981-1014. doi: 10.1016/j.progpolymsci.2011.02.001.
  • 27. Cole P, Bishop J, Beckstead J, Titus R, Ryan R. Effect of Amphotericin B nanodisks on Leishmania major infected mice. Pharm Anal Acta. 2014;5. doi: 10.4172/2153-2435.1000311. [PubMed: 25584195]. [PubMed Central: PMC4288788].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments